Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up

Factors for Visual Acuity Improvement After Anti-VEGF Treatment of Wet Age-Related Macular Degeneration in China: 12 Months Follow up

Purpose: To evaluate the treatment solutions and effectiveness of intravitreal ranibizumab (RBZ) or conbercept in patients with wet age-related macular degeneration (wAMD) in a real-life setting in China.Methods: The medical records of 368 patients with wAMD who started RBZ or conbercept treatment b...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Lu, Wenzhi Huang, Yuehong Zhang, Xiongfei Huang, Xu Zhang, Haizhi Ma, Guoliang Ren, Feng Shi, Lihui Kuang, Shigang Yan, Shuke Luo, Junyan Zhang, Jingfang He, Weizhong Yang, Zongyin Gao, Yunxia Leng
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
age-related macular degeneration
ranibizumab
conbercept
polypoidal choroidal vasculopathy (PCV)
choroidal neovascularization (CNV)
Medicine (General)
R5-920
Online Access:https://doaj.org/article/ac9e16d329af4ba2be07b0a004af0630
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/ac9e16d329af4ba2be07b0a004af0630

Similar Items